Darwin Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$58.3K Buy
+149
New +$59.5K 0.02% 286
2026
Q2
– Hold
0
– – – 610
2025
Q2
– Sell
-10
Closed -$3.69K – 634
2025
Q1
$3.69K Hold
10
– – ﹤0.01% 465
2024
Q4
$3.69K Hold
10
– – ﹤0.01% 465
2024
Q3
$5.2K Buy
+10
New +$5.34K ﹤0.01% 455
2020
Q2
– Sell
-381
Closed -$86K – 316
2020
Q1
$86K Buy
+381
New +$104K 0.03% 188

Other funds holding ELV

Darwin Wealth Management's ELV Position: Q3 2026 in Review

Darwin Wealth Management opened a new position in Elevance Health (ELV) in Q3 2026: 149 shares worth $58.3K. The stake represents 0.02% of the portfolio and ranks #286 among its holdings. This is a return to the name: Darwin Wealth Management previously reported a position in ELV as recently as Q1 2025.

Darwin Wealth Management first reported a position in ELV in Q1 2020 and has held it in 5 quarters since. The position peaked at $86K in Q1 2020. 1,031 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Darwin Wealth Management held 149 shares of Elevance Health worth $58.3K as of Q3 2026.
  • Elevance Health was a new Darwin Wealth Management position in Q3 2026.
  • Elevance Health made up 0.02% of Darwin Wealth Management's portfolio in Q3 2026, its #286 holding.
  • Darwin Wealth Management first reported a position in Elevance Health in Q1 2020 and has held it in 5 quarters since.
  • Darwin Wealth Management's Elevance Health position peaked at $86K in Q1 2020.
  • 1,031 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Darwin Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.